Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 522 entries
Sorted by: Best Match Show Resources per page
Publisher Correction: Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.

BMC nephrology

[No authors listed]
PMID: 28978302
BMC Nephrol. 2017 Oct 04;18(1):306. doi: 10.1186/s12882-017-0716-1.

No abstract available.

Cite
Publisher Correction: Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients. BMC Nephrol. 2017;18(1):306doi: 10.1186/s12882-017-0716-1.
(2017). Publisher Correction: Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients. BMC nephrology, 18(1), 306. https://doi.org/10.1186/s12882-017-0716-1
"Publisher Correction: Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients." BMC nephrology vol. 18,1 (2017): 306. doi: https://doi.org/10.1186/s12882-017-0716-1
Publisher Correction: Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients. BMC Nephrol. 2017 Oct 04;18(1):306. doi: 10.1186/s12882-017-0716-1. PMID: 28978302; PMCID: PMC5627453.
Copy Download .nbib Format: NLM
Development of a chronic kidney disease patient navigator program.

BMC nephrology

Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV.
PMID: 26024966
BMC Nephrol. 2015 May 03;16:69. doi: 10.1186/s12882-015-0060-2.

BACKGROUND: Chronic Kidney Disease (CKD) is a public health problem and there is a scarcity of type 2 CKD translational research that incorporates educational tools. Patient navigators have been shown to be effective at reducing disparities and improving outcomes...

Cite
Jolly SE, Navaneethan SD, Schold JD, et al. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015;16:69doi: 10.1186/s12882-015-0060-2.
Jolly, S. E., Navaneethan, S. D., Schold, J. D., Arrigain, S., Konig, V., Burrucker, Y. K., Hyland, J., Dann, P., Tucky, B. H., Sharp, J. W., & Nally, J. V. (2015). Development of a chronic kidney disease patient navigator program. BMC nephrology, 1669. https://doi.org/10.1186/s12882-015-0060-2
Jolly, Stacey E, et al. "Development of a chronic kidney disease patient navigator program." BMC nephrology vol. 16 (2015): 69. doi: https://doi.org/10.1186/s12882-015-0060-2
Jolly SE, Navaneethan SD, Schold JD, Arrigain S, Konig V, Burrucker YK, Hyland J, Dann P, Tucky BH, Sharp JW, Nally JV. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015 May 03;16:69. doi: 10.1186/s12882-015-0060-2. PMID: 26024966; PMCID: PMC4459709.
Copy Download .nbib Format: NLM
A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development.

BMC nephrology

Khandelwal A, Trinkaus MA, Ghaffar H, Jothy S, Goldstein MB.
PMID: 27686684
BMC Nephrol. 2016 Sep 29;17(1):140. doi: 10.1186/s12882-016-0349-9.

BACKGROUND: Immunotactoid glomerulopathy (ITG) is a rare cause of proteinuria characterized by organized microtubular deposits in the glomerulus. ITG has been associated with underlying lymphoproliferative disorders and any renal impairment may be reversible with treatment of the concomitant hematologic...

Cite
Khandelwal A, Trinkaus MA, Ghaffar H, et al. A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development. BMC Nephrol. 2016;17(1):140doi: 10.1186/s12882-016-0349-9.
Khandelwal, A., Trinkaus, M. A., Ghaffar, H., Jothy, S., & Goldstein, M. B. (2016). A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development. BMC nephrology, 17(1), 140. https://doi.org/10.1186/s12882-016-0349-9
Khandelwal, Aditi, et al. "A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development." BMC nephrology vol. 17,1 (2016): 140. doi: https://doi.org/10.1186/s12882-016-0349-9
Khandelwal A, Trinkaus MA, Ghaffar H, Jothy S, Goldstein MB. A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development. BMC Nephrol. 2016 Sep 29;17(1):140. doi: 10.1186/s12882-016-0349-9. PMID: 27686684; PMCID: PMC5043628.
Copy Download .nbib Format: NLM
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol.

BMC nephrology

Stringer S, Sharma P, Dutton M, Jesky M, Ng K, Kaur O, Chapple I, Dietrich T, Ferro C, Cockwell P.
PMID: 23617441
BMC Nephrol. 2013 Apr 25;14:95. doi: 10.1186/1471-2369-14-95.

BACKGROUND: Chronic kidney disease (CKD) affects up to 16% of the adult population and is associated with significant morbidity and mortality. People at highest risk from progressive CKD are defined by a sustained decline in estimated glomerular filtration rate...

Cite
Stringer S, Sharma P, Dutton M, et al. The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol. 2013;14:95doi: 10.1186/1471-2369-14-95.
Stringer, S., Sharma, P., Dutton, M., Jesky, M., Ng, K., Kaur, O., Chapple, I., Dietrich, T., Ferro, C., & Cockwell, P. (2013). The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC nephrology, 1495. https://doi.org/10.1186/1471-2369-14-95
Stringer, Stephanie, et al. "The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol." BMC nephrology vol. 14 (2013): 95. doi: https://doi.org/10.1186/1471-2369-14-95
Stringer S, Sharma P, Dutton M, Jesky M, Ng K, Kaur O, Chapple I, Dietrich T, Ferro C, Cockwell P. The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol. 2013 Apr 25;14:95. doi: 10.1186/1471-2369-14-95. PMID: 23617441; PMCID: PMC3664075.
Copy Download .nbib Format: NLM
Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges.

BMC nephrology

Kissling S, Legallais C, Pruijm M, Teta D, Vogt B, Burnier M, Rondeau E, Ridel C.
PMID: 28279164
BMC Nephrol. 2017 Mar 09;18(1):84. doi: 10.1186/s12882-017-0500-2.

No abstract available.

Cite
Kissling S, Legallais C, Pruijm M, et al. Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges. BMC Nephrol. 2017;18(1):84doi: 10.1186/s12882-017-0500-2.
Kissling, S., Legallais, C., Pruijm, M., Teta, D., Vogt, B., Burnier, M., Rondeau, E., & Ridel, C. (2017). Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges. BMC nephrology, 18(1), 84. https://doi.org/10.1186/s12882-017-0500-2
Kissling, Sébastien, et al. "Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges." BMC nephrology vol. 18,1 (2017): 84. doi: https://doi.org/10.1186/s12882-017-0500-2
Kissling S, Legallais C, Pruijm M, Teta D, Vogt B, Burnier M, Rondeau E, Ridel C. Erratum to: A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges. BMC Nephrol. 2017 Mar 09;18(1):84. doi: 10.1186/s12882-017-0500-2. PMID: 28279164; PMCID: PMC5345175.
Copy Download .nbib Format: NLM
Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series.

BMC nephrology

de Nattes T, Moreau-Grangé L, Vezzosi D, Hadoux J, Hie M, Guerrot D, Grangé S.
PMID: 32039708
BMC Nephrol. 2020 Feb 10;21(1):44. doi: 10.1186/s12882-020-1712-4.

Following publication of the original article [1], we have been notified that the name of one author was spelled incorrectly as Julien Haddoux, when the correct spelling is Julien Hadoux.

Cite
de Nattes T, Moreau-Grangé L, Vezzosi D, et al. Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series. BMC Nephrol. 2020;21(1):44doi: 10.1186/s12882-020-1712-4.
de Nattes, T., Moreau-Grangé, L., Vezzosi, D., Hadoux, J., Hie, M., Guerrot, D., & Grangé, S. (2020). Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series. BMC nephrology, 21(1), 44. https://doi.org/10.1186/s12882-020-1712-4
de Nattes, Tristan, et al. "Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series." BMC nephrology vol. 21,1 (2020): 44. doi: https://doi.org/10.1186/s12882-020-1712-4
de Nattes T, Moreau-Grangé L, Vezzosi D, Hadoux J, Hie M, Guerrot D, Grangé S. Correction to: Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series. BMC Nephrol. 2020 Feb 10;21(1):44. doi: 10.1186/s12882-020-1712-4. PMID: 32039708; PMCID: PMC7008570.
Copy Download .nbib Format: NLM
Correction to: Quality of life improved for patients after starting dialysis but is impaired, initially, for their partners: a multi-centre, longitudinal study.

BMC nephrology

Moore C, Carter LA, Mitra S, Skevington S, Wearden A.
PMID: 32631248
BMC Nephrol. 2020 Jul 06;21(1):254. doi: 10.1186/s12882-020-01858-x.

An amendment to this paper has been published and can be accessed via the original article.

Cite
Moore C, Carter LA, Mitra S, et al. Correction to: Quality of life improved for patients after starting dialysis but is impaired, initially, for their partners: a multi-centre, longitudinal study. BMC Nephrol. 2020;21(1):254doi: 10.1186/s12882-020-01858-x.
Moore, C., Carter, L. A., Mitra, S., Skevington, S., & Wearden, A. (2020). Correction to: Quality of life improved for patients after starting dialysis but is impaired, initially, for their partners: a multi-centre, longitudinal study. BMC nephrology, 21(1), 254. https://doi.org/10.1186/s12882-020-01858-x
Moore, Currie, et al. "Correction to: Quality of life improved for patients after starting dialysis but is impaired, initially, for their partners: a multi-centre, longitudinal study." BMC nephrology vol. 21,1 (2020): 254. doi: https://doi.org/10.1186/s12882-020-01858-x
Moore C, Carter LA, Mitra S, Skevington S, Wearden A. Correction to: Quality of life improved for patients after starting dialysis but is impaired, initially, for their partners: a multi-centre, longitudinal study. BMC Nephrol. 2020 Jul 06;21(1):254. doi: 10.1186/s12882-020-01858-x. PMID: 32631248; PMCID: PMC7336627.
Copy Download .nbib Format: NLM
Understanding the holistic experiences of living with a kidney transplant: an interpretative phenomenological study (protocol).

BMC nephrology

McKeaveney C, Noble H, Courtney AE, Gill P, Griffin S, Johnston W, Maxwell AP, Teasdale F, Reid J.
PMID: 32527229
BMC Nephrol. 2020 Jun 11;21(1):222. doi: 10.1186/s12882-020-01860-3.

BACKGROUND: Currently very little is known about the perceptions and experiences of kidney transplant recipients from a qualitative perspective. As highlighted by the European Kidney Health Alliance recommendations, providing holistic care to kidney patients is important however this is...

Cite
McKeaveney C, Noble H, Courtney AE, et al. Understanding the holistic experiences of living with a kidney transplant: an interpretative phenomenological study (protocol). BMC Nephrol. 2020;21(1):222doi: 10.1186/s12882-020-01860-3.
McKeaveney, C., Noble, H., Courtney, A. E., Gill, P., Griffin, S., Johnston, W., Maxwell, A. P., Teasdale, F., & Reid, J. (2020). Understanding the holistic experiences of living with a kidney transplant: an interpretative phenomenological study (protocol). BMC nephrology, 21(1), 222. https://doi.org/10.1186/s12882-020-01860-3
McKeaveney, C, et al. "Understanding the holistic experiences of living with a kidney transplant: an interpretative phenomenological study (protocol)." BMC nephrology vol. 21,1 (2020): 222. doi: https://doi.org/10.1186/s12882-020-01860-3
McKeaveney C, Noble H, Courtney AE, Gill P, Griffin S, Johnston W, Maxwell AP, Teasdale F, Reid J. Understanding the holistic experiences of living with a kidney transplant: an interpretative phenomenological study (protocol). BMC Nephrol. 2020 Jun 11;21(1):222. doi: 10.1186/s12882-020-01860-3. PMID: 32527229; PMCID: PMC7289222.
Copy Download .nbib Format: NLM
Caffeine-induced hypokalemia: a case report.

BMC nephrology

Han MJ, Kim SH, Shin JH, Hwang JH.
PMID: 34243702
BMC Nephrol. 2021 Jul 09;22(1):260. doi: 10.1186/s12882-021-02465-0.

BACKGROUND: With an increase in the global popularity of coffee, caffeine is one of the most consumed ingredients of modern times. However, the consumption of massive amounts of caffeine can lead to severe hypokalemia.CASE PRESENTATION: A 29-year-old man without...

Cite
Han MJ, Kim SH, Shin JH, et al. Caffeine-induced hypokalemia: a case report. BMC Nephrol. 2021;22(1):260doi: 10.1186/s12882-021-02465-0.
Han, M. J., Kim, S. H., Shin, J. H., & Hwang, J. H. (2021). Caffeine-induced hypokalemia: a case report. BMC nephrology, 22(1), 260. https://doi.org/10.1186/s12882-021-02465-0
Han, Min Jee, et al. "Caffeine-induced hypokalemia: a case report." BMC nephrology vol. 22,1 (2021): 260. doi: https://doi.org/10.1186/s12882-021-02465-0
Han MJ, Kim SH, Shin JH, Hwang JH. Caffeine-induced hypokalemia: a case report. BMC Nephrol. 2021 Jul 09;22(1):260. doi: 10.1186/s12882-021-02465-0. PMID: 34243702; PMCID: PMC8272359.
Copy Download .nbib Format: NLM
Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis.

BMC nephrology

Wei SY, Guo S, Feng B, Ning SW, Du XY.
PMID: 34823491
BMC Nephrol. 2021 Nov 25;22(1):392. doi: 10.1186/s12882-021-02606-5.

BACKGROUND: IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide, and its diagnosis depends mainly on renal biopsy. However, there is no specific treatment for IgAN. Moreover, its causes and underlying molecular events require further exploration.METHODS:...

Cite
Wei SY, Guo S, Feng B, et al. Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis. BMC Nephrol. 2021;22(1):392doi: 10.1186/s12882-021-02606-5.
Wei, S. Y., Guo, S., Feng, B., Ning, S. W., & Du, X. Y. (2021). Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis. BMC nephrology, 22(1), 392. https://doi.org/10.1186/s12882-021-02606-5
Wei, Shi-Yao, et al. "Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis." BMC nephrology vol. 22,1 (2021): 392. doi: https://doi.org/10.1186/s12882-021-02606-5
Wei SY, Guo S, Feng B, Ning SW, Du XY. Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis. BMC Nephrol. 2021 Nov 25;22(1):392. doi: 10.1186/s12882-021-02606-5. PMID: 34823491; PMCID: PMC8620631.
Copy Download .nbib Format: NLM
Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis.

BMC nephrology

Flythe JE, Karlsson N, Sundgren A, Cordero P, Grandinetti A, Cremisi H, Rydén A.
PMID: 34162354
BMC Nephrol. 2021 Jun 23;22(1):233. doi: 10.1186/s12882-021-02440-9.

BACKGROUND: Patient-reported outcome (PRO) instruments should capture the experiences of disease and treatment that patients consider most important in order to inform patient-centred care and product development. The aim of this study was to develop a preliminary conceptual model...

Cite
Flythe JE, Karlsson N, Sundgren A, et al. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis. BMC Nephrol. 2021;22(1):233doi: 10.1186/s12882-021-02440-9.
Flythe, J. E., Karlsson, N., Sundgren, A., Cordero, P., Grandinetti, A., Cremisi, H., & Rydén, A. (2021). Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis. BMC nephrology, 22(1), 233. https://doi.org/10.1186/s12882-021-02440-9
Flythe, Jennifer E, et al. "Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis." BMC nephrology vol. 22,1 (2021): 233. doi: https://doi.org/10.1186/s12882-021-02440-9
Flythe JE, Karlsson N, Sundgren A, Cordero P, Grandinetti A, Cremisi H, Rydén A. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis. BMC Nephrol. 2021 Jun 23;22(1):233. doi: 10.1186/s12882-021-02440-9. PMID: 34162354; PMCID: PMC8220773.
Copy Download .nbib Format: NLM
Graft function and pregnancy outcomes after kidney transplantation.

BMC nephrology

Schwarz A, Schmitt R, Einecke G, Keller F, Bode U, Haller H, Guenter HH.
PMID: 35022021
BMC Nephrol. 2022 Jan 12;23(1):27. doi: 10.1186/s12882-022-02665-2.

BACKGROUND: After kidney transplantation, pregnancy and graft function may have a reciprocal interaction. We evaluated the influence of graft function on the course of pregnancy and vice versa.METHODS: We performed a retrospective observational study of 92 pregnancies beyond the...

Cite
Schwarz A, Schmitt R, Einecke G, et al. Graft function and pregnancy outcomes after kidney transplantation. BMC Nephrol. 2022;23(1):27doi: 10.1186/s12882-022-02665-2.
Schwarz, A., Schmitt, R., Einecke, G., Keller, F., Bode, U., Haller, H., & Guenter, H. H. (2022). Graft function and pregnancy outcomes after kidney transplantation. BMC nephrology, 23(1), 27. https://doi.org/10.1186/s12882-022-02665-2
Schwarz, Anke, et al. "Graft function and pregnancy outcomes after kidney transplantation." BMC nephrology vol. 23,1 (2022): 27. doi: https://doi.org/10.1186/s12882-022-02665-2
Schwarz A, Schmitt R, Einecke G, Keller F, Bode U, Haller H, Guenter HH. Graft function and pregnancy outcomes after kidney transplantation. BMC Nephrol. 2022 Jan 12;23(1):27. doi: 10.1186/s12882-022-02665-2. PMID: 35022021.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 522 entries